Story perspectives

Trump Buys $1M Lilly, West Pharma Stocks, Sparks Ethics Outcry

5/26/2026

Summary

Story summary

President Donald Trump bought $680,000 of Eli Lilly stock and $250,000-$500,000 of West Pharmaceutical Services stock between January and March 2026, disclosed May 14.
The purchases coincided with Medicare reimbursement proposals and the FDA’s April approval of Lilly’s Foundayo weight-loss pill in 50 days.
Legal ethicist Kathleen Clark warned of a conflict of interest, while Democratic lawmakers such as Senator Andy Kim urged a ban on presidents trading individual stocks.

1 of 1

Story summary

President Donald Trump bought $680,000 of Eli Lilly stock and $250,000-$500,000 of West Pharmaceutical Services stock between January and March 2026, disclosed May 14.
The purchases coincided with Medicare reimbursement proposals and the FDA’s April approval of Lilly’s Foundayo weight-loss pill in 50 days.
Legal ethicist Kathleen Clark warned of a conflict of interest, while Democratic lawmakers such as Senator Andy Kim urged a ban on presidents trading individual stocks.